In imiquimod-induced dermatitis, IL-17A, IL-17F, and IL-22 may be mostly derived from Th17 cells or γδT17 cells, while CXCL1, CXCL2, CCL20, and IL-17C may be mainly produced by epidermal keratinocytes. Here, IL22 is linked to skin disorder.